Zenocutuzumab (Anti-HER2 & HER3)
Product Specifications
CAS Number
1969309-56-5
Synonyms
MCLA-128, PB4188, R040517
SKU
C00930-1mg
Target
HER2
Applications
Protein Tyrosine Kinase
Additionnal Information
Zenocutuzumab is a humanized bispecific IgG1 antibody targeting HER2 and HER3 to enhance antibody-dependent cellular cytotoxicity (ADCC) and inhibit tumor growth. It is being developed for the treatment of cancers overexpressing HER2 and HER3, leveraging dual targeting for enhanced antitumor activity. M. W 145.88 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
